HBIO vs AVR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

HBIO

55.2
AI Score
VS
HBIO Wins

AVR

51.4
AI Score

Investment Advisor Scores

HBIO

55score
Recommendation
HOLD

AVR

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HBIO AVR Winner
Revenue 43.48M 1.50M HBIO
Net Income -6.33M -52.12M HBIO
Net Margin -14.6% -3467.6% HBIO
Operating Income -2.15M -55.00M HBIO
ROE -85.4% -20.7% AVR
ROA -8.3% -19.1% HBIO
Total Assets 76.29M 272.51M AVR
Cash 6.50M 249.90M AVR
Current Ratio 1.87 14.20 AVR
Free Cash Flow -1.45M -50.26M HBIO

Relative Price Performance (Last 90 Days)

HBIO 1M: +4.2% · 3M: +39.8% AVR 1M: -19.5% · 3M: -24.5%

Current Technical Phase

HBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.6% over 20 days), RSI 58

RSI (14): 58.1 · Price: $8.39

AVR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.0%), weak momentum, RSI 31

RSI (14): 30.8 · Price: $6.14

Fundamentals Snapshot

Metric HBIO AVR
Market Cap — —
Forward P/E 13.2 -5.2
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.1% 0.6%
Gross Margin 0.6% 0.7%
Operating Margin 0.0% -30.7%
EPS -2.31 -1.95
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, HBIO is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.